Abstract
DUPILUMAB REDUCED ORAL CORTICOSTEROID USE AND IMPROVED CLINICAL OUTCOMES REGARDLESS OF BASELINE OCS DOSE IN PATIENTS WITH UNCONTROLLED, SEVERE ASTHMA IN THE LIBERTY ASTHMA VENTURE STUDY
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
